Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | Director | August 23, 2018 | August 24, 2018 |
| Nielsen Holdings plcNLSN · Entity 16431 | Director | March 31, 2021 | April 01, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date August 23, 2018 · Filed August 24, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 62,369 |
Reported balance
After 2018-08-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-08-23 · Exercise / conversion · Acquired 2,671 · Balance 62,369 F1: This balance increased 155 shares due to exempt transactions such as dividend reinvestment. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 64,182 |
Reported balance
After 2018-08-23 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-08-23 · Exercise / conversion · Acquired 1,813 · Balance 64,182 |
| Ordinary SharesSEC Table I · non-derivative | Direct | 60,964 |
Reported balance
After 2018-08-23 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2018-08-23 · Sale · Disposed 3,218 · Balance 60,964 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.96 · Expires 2019-04-27 | Direct | 0 |
Reported balance
After 2018-08-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-08-23 · Exercise / conversion · Disposed 2,671 · Balance 0 F2: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.13 · Expires 2020-05-03 | Direct | 0 |
Reported balance
After 2018-08-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-08-23 · Exercise / conversion · Disposed 1,813 · Balance 0 F3: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. |
Filing footnotes · ownership attribution and instrument terms
F1: This balance increased 155 shares due to exempt transactions such as dividend reinvestment.
F2: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F3: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
Nielsen Holdings plc
Report date March 31, 2021 · Filed April 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 247,580.901 |
Reported balance
After 2021-03-31 transaction · row 1
1 source rowRow 1 · 2021-03-31 · Grant · Acquired 944.33 · Balance 247,580.901 F1: Represents deferred stock units issued to the Reporting Person at the closing trading price as of March 31, 2021 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock units issued to the Reporting Person at the closing trading price as of March 31, 2021 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2016 Filed Dec 8, 2016 10:26 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 161.358 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-154048 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,854.712 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 14:48 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 443.35 | $53.57 | $23,750.26 |
DisclosureSEC source: 0001209191-16-143534 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,693.354 F1 · kind: Represents deferred stock units issued to the Reporting Person at the closing trading price as of September 30, 2016 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of September 30, 2016 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 10:09 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 127.277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-140868 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,250.004 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.